Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020
Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), by Application (Research, Clinical Diagnostics), by End User (Hospitals, Pharmaceutical Industry & CROs, Academics, Others), by Geography– Global Forecast to 2020
Radioimmunoassay technique is basically used to measure the concentration of specific antigens by using specific antibodies. This technique is mainly used for research purposes rather than for diagnostics purposes. The global radioimmunoassay (RIA) market constituted 2.3% share of the global immunoassay market.
Radioimmunoassay has applications in the field of clinical diagnostics, and is used in hospitals, contract research organizations (CRO), laboratories, pharmaceutical companies, and others. It is used for the early detection and diagnosis of cancer; recognition of endocrinological disorders; and various other applications. Pharmaceuticals companies use the RIA techniques for drug testing. Radioimmunoassay also has it application in the research purpose, and contributed a share of 65.9% to the overall radioimmunoassay market in 2014.
The global radioimmunoassay market is expected to reach $428.4 million by 2020, at a CAGR of 3.5% during the forecast period from 2015 to 2020. The growing aging population and rise in the usage of radioimmunoassay technique in Oncology are the major factors influencing this market.
There are various application areas for RIA in research and diagnostics, which are infectious disease testing, endocrine testing, allergy testing, oncology testing, toxicology testing, and autoimmune disease testing. Out of all the application segments, oncology testing is the largest application segment, and is expected to hold the largest market share in the near future. The major reason behind these is the growth in the oncology market due to various factors, such as the increasing incidence rate of cancer, growth in aging population, urbanization with heavy pollution, and others.
The global radioimmunoassay market report studies the major regions, namely, North America, Europe, Asia, and the Rest of the World (RoW).
In 2015, Europe is estimated to account for the largest share of 35.1% in the global radioimmunoassay market. As radioimmunoassay is one of the key instruments used in the life sciences sector, increased investments in life sciences are expected to fuel the growth of the radioimmunoassay market in the region. However, the growth in the European radioimmunoassay market is driven by the outsourcing of drug discovery, rising government investments in life sciences, and increasing prevalence of infectious diseases as well as cancer in this region.
The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis. Some of the companies profiled in this report are DIAsource ImmunoAssays SA (Belgium), Beckman Coulter, Inc. (U.S.), IBL International (A Tecan Company) (Germany), PerkinElmer, Inc. (U.S.), DRG International, Inc. (U.S.), MP Biomedicals, LLC (U.S.), Cisbio (France), Euro Diagnostica AB (Sweden), DiaSorin S.p.A. (Italy), EMD Millipore (U.S.), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), and Stratec Biomedical AG (Germany), among others.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. All of these together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities of the global Radioimmunoassay (RIA) market.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.
The report provides insights on the following pointers:
Radioimmunoassay technique is basically used to measure the concentration of specific antigens by using specific antibodies. This technique is mainly used for research purposes rather than for diagnostics purposes. The global radioimmunoassay (RIA) market constituted 2.3% share of the global immunoassay market.
Radioimmunoassay has applications in the field of clinical diagnostics, and is used in hospitals, contract research organizations (CRO), laboratories, pharmaceutical companies, and others. It is used for the early detection and diagnosis of cancer; recognition of endocrinological disorders; and various other applications. Pharmaceuticals companies use the RIA techniques for drug testing. Radioimmunoassay also has it application in the research purpose, and contributed a share of 65.9% to the overall radioimmunoassay market in 2014.
The global radioimmunoassay market is expected to reach $428.4 million by 2020, at a CAGR of 3.5% during the forecast period from 2015 to 2020. The growing aging population and rise in the usage of radioimmunoassay technique in Oncology are the major factors influencing this market.
There are various application areas for RIA in research and diagnostics, which are infectious disease testing, endocrine testing, allergy testing, oncology testing, toxicology testing, and autoimmune disease testing. Out of all the application segments, oncology testing is the largest application segment, and is expected to hold the largest market share in the near future. The major reason behind these is the growth in the oncology market due to various factors, such as the increasing incidence rate of cancer, growth in aging population, urbanization with heavy pollution, and others.
The global radioimmunoassay market report studies the major regions, namely, North America, Europe, Asia, and the Rest of the World (RoW).
In 2015, Europe is estimated to account for the largest share of 35.1% in the global radioimmunoassay market. As radioimmunoassay is one of the key instruments used in the life sciences sector, increased investments in life sciences are expected to fuel the growth of the radioimmunoassay market in the region. However, the growth in the European radioimmunoassay market is driven by the outsourcing of drug discovery, rising government investments in life sciences, and increasing prevalence of infectious diseases as well as cancer in this region.
The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis. Some of the companies profiled in this report are DIAsource ImmunoAssays SA (Belgium), Beckman Coulter, Inc. (U.S.), IBL International (A Tecan Company) (Germany), PerkinElmer, Inc. (U.S.), DRG International, Inc. (U.S.), MP Biomedicals, LLC (U.S.), Cisbio (France), Euro Diagnostica AB (Sweden), DiaSorin S.p.A. (Italy), EMD Millipore (U.S.), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), and Stratec Biomedical AG (Germany), among others.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. All of these together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities of the global Radioimmunoassay (RIA) market.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.
The report provides insights on the following pointers:
- Product Analysis and Development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the Global Radioimmunoassay (RIA) market are provided.
- Market Development: Comprehensive information about lucrative emerging markets is provided. The report also analyzes the markets for Radioimmunoassay (RIA) across various regions, exploit new distribution channels, new clientele base and different pricing policies.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the Global Radioimmunoassay (RIA) market is provided. Detailed description regarding the related and unrelated diversification pertaining to this market is also provided.
- Competitive Assessment: An in-depth assessment of market shares and company share analysis of the key players forecasted till 2020 is provided. Develop business strategies and manufacturing capabilities of leading players enhance the bottom line of the companies in the Radioimmunoassay (RIA) market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF THE RADIOIMMUNOASSAY (RIA) MARKET
2.2 ARRIVING AT THE RADIOIMMUNOASSAY (RIA) MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.2.2 MACRO INDICATOR-BASED APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 RADIOIMMUNOASSAY (RIA) MARKET: COMPARISON WITH IMMUNOASSAY MARKET (PARENT MARKET)
4.3 MARKET DRIVERS AND INHIBITORS
5 RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE
5.1 INTRODUCTION
5.2 REAGENTS & KITS MARKET
5.3 ANALYZERS MARKET
6 RADIOIMMUNOASSAY (RIA) MARKET, BY END USER
6.1 INTRODUCTION
6.2 HOSPITAL
6.3 PHARMACEUTICAL INDUSTRY AND CRO
6.4 ACADEMICS
6.5 CLINICAL DIAGNOSTIC LABORATORIES
7 RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 RESEARCH
7.3 CLINICAL DIAGNOSTICS
8 RADIOIMMUNOASSAY MARKET, BY GEOGRAPHY
8.1 INTRODUCTION
8.2 EUROPE
8.2.1 BY TYPE
8.2.2 BY APPLICATION
8.2.3 BY END USER
8.2.4 BY COUNTRY
8.2.4.1 GERMANY
8.2.4.2 FRANCE
8.2.4.3 U.K.
8.2.4.4 ITALY
8.2.4.5 SPAIN
8.3 NORTH AMERICA
8.3.1 BY TYPE
8.3.2 BY APPLICATION
8.3.3 BY END USER
8.3.4 BY COUNTRY
8.3.4.1 U.S.
8.3.4.2 CANADA
8.3.4.3 MEXICO
8.4 ASIA
8.4.1 BY TYPE
8.4.2 BY APPLICATION
8.4.3 BY END USER
8.4.4 BY COUNTRY
8.4.4.1 CHINA
8.4.4.2 JAPAN
8.4.4.3 INDIA
8.4.4.4 REPUBLIC OF KOREA
8.5 REST OF THE WORLD (ROW)
8.5.1 BY TYPE
8.5.2 BY APPLICATION
8.5.3 BY END USER
9 COMPETITIVE LANDSCAPE
9.1 COMPANY SHARE ANALYSIS
10 COMPANY PROFILES
(Business Overview, Products & Services, Key Insights, Recent Developments, MnM View)*
10.1 DIASORIN S.P.A.
10.2 EURO DIAGNOSTICA AB
10.3 MERCK MILLIPORE CORPORATION
10.4 DIASOURCE IMMUNOSSAYS S.A
10.5 STRATEC BIOMEDICALS AG
10.6 BERTHOLD TECHNOLOGIES GMBH & CO. KG
10.7 IZOTOP
10.8 BECKMAN COULTER, INC.
10.9 CISBIO
10.10 MP BIOMEDICALS LLC
10.11 PERKINELMER, INC.
10.12 IBL INTERNATIONAL (A TECAN COMPANY)
10.13 DRG INTERNATIONAL, INC.
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.
11 APPENDIX
11.1 CUSTOMIZATION OPTIONS
11.1.1 PRODUCT ANALYSIS
11.1.2 BRAND/PRODUCT PERCEPTION MATRIX
11.1.3 PORTER’S FIVE FORCES ANALYSIS
11.2 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF THE RADIOIMMUNOASSAY (RIA) MARKET
2.2 ARRIVING AT THE RADIOIMMUNOASSAY (RIA) MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.2.2 MACRO INDICATOR-BASED APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 RADIOIMMUNOASSAY (RIA) MARKET: COMPARISON WITH IMMUNOASSAY MARKET (PARENT MARKET)
4.3 MARKET DRIVERS AND INHIBITORS
5 RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE
5.1 INTRODUCTION
5.2 REAGENTS & KITS MARKET
5.3 ANALYZERS MARKET
6 RADIOIMMUNOASSAY (RIA) MARKET, BY END USER
6.1 INTRODUCTION
6.2 HOSPITAL
6.3 PHARMACEUTICAL INDUSTRY AND CRO
6.4 ACADEMICS
6.5 CLINICAL DIAGNOSTIC LABORATORIES
7 RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 RESEARCH
7.3 CLINICAL DIAGNOSTICS
8 RADIOIMMUNOASSAY MARKET, BY GEOGRAPHY
8.1 INTRODUCTION
8.2 EUROPE
8.2.1 BY TYPE
8.2.2 BY APPLICATION
8.2.3 BY END USER
8.2.4 BY COUNTRY
8.2.4.1 GERMANY
8.2.4.2 FRANCE
8.2.4.3 U.K.
8.2.4.4 ITALY
8.2.4.5 SPAIN
8.3 NORTH AMERICA
8.3.1 BY TYPE
8.3.2 BY APPLICATION
8.3.3 BY END USER
8.3.4 BY COUNTRY
8.3.4.1 U.S.
8.3.4.2 CANADA
8.3.4.3 MEXICO
8.4 ASIA
8.4.1 BY TYPE
8.4.2 BY APPLICATION
8.4.3 BY END USER
8.4.4 BY COUNTRY
8.4.4.1 CHINA
8.4.4.2 JAPAN
8.4.4.3 INDIA
8.4.4.4 REPUBLIC OF KOREA
8.5 REST OF THE WORLD (ROW)
8.5.1 BY TYPE
8.5.2 BY APPLICATION
8.5.3 BY END USER
9 COMPETITIVE LANDSCAPE
9.1 COMPANY SHARE ANALYSIS
10 COMPANY PROFILES
(Business Overview, Products & Services, Key Insights, Recent Developments, MnM View)*
10.1 DIASORIN S.P.A.
10.2 EURO DIAGNOSTICA AB
10.3 MERCK MILLIPORE CORPORATION
10.4 DIASOURCE IMMUNOSSAYS S.A
10.5 STRATEC BIOMEDICALS AG
10.6 BERTHOLD TECHNOLOGIES GMBH & CO. KG
10.7 IZOTOP
10.8 BECKMAN COULTER, INC.
10.9 CISBIO
10.10 MP BIOMEDICALS LLC
10.11 PERKINELMER, INC.
10.12 IBL INTERNATIONAL (A TECAN COMPANY)
10.13 DRG INTERNATIONAL, INC.
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.
11 APPENDIX
11.1 CUSTOMIZATION OPTIONS
11.1.1 PRODUCT ANALYSIS
11.1.2 BRAND/PRODUCT PERCEPTION MATRIX
11.1.3 PORTER’S FIVE FORCES ANALYSIS
11.2 RELATED REPORTS
LIST OF TABLES
Table 1 IMMUNOASSAY MARKET SIZE & RADIOIMMUNOASSAY MARKET SIZE, 2014 (USD MILLION)
Table 2 RADIOIMMUNOASSAY (RIA) MARKET: COMPARISON WITH IMMUNOASSAY MARKET (PARENT MARKET), 2013–2020 (USD MILLION)
Table 3 RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 4 RADIOIMMUNOASSAY (RIA) MARKET, BY END-USER, 2013-2020 (USD MILLION)
Table 5 RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 6 RADIOIMMUNOASSAY MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 7 RADIOIMMUNOASSAY (RIA) MARKET: DRIVERS AND INHIBITORS
Table 8 RADIOIMMUNOASSAY MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 9 RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 10 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 11 RADIOIMMUNOASSAY (RIA) MARKET, BY END-USERS, 2013–2020 (USD MILLION)
Table 12 RADIOIMMUNOASSAY (RIA) MARKET IN HOSPITALS, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 13 RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY AND CRO, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 14 RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 15 RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 16 RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 17 RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 18 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 19 RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 20 RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 21 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 22 RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 23 RADIOIMMUNOASSAY (RIA) MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 24 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 25 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 26 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 27 EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 28 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 29 GERMANY RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 30 GERMANY RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 31 FRANCE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 32 FRANCE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 33 U.K. RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 34 U.K. RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 35 ITALY RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 36 ITALY RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 37 SPAIN RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 38 SPAIN RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 39 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 40 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 41 NORTH AMERICA RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 42 NORTH AMERICA RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 43 NORTH-AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY END-USER, 2013-2020 (USD MILLION)
Table 44 U.S. RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 45 U.S. RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 46 CANADA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 47 CANADA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 48 MEXICO RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 49 MEXICO RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 50 ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 51 ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 52 ASIA RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 53 ASIA RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 54 ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 55 CHINA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 56 CHINA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 57 JAPAN RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 58 JAPAN RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 59 INDIA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 60 INDIA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 61 REPUBLIC OF KOREA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 62 REPUBLIC OF KOREA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 63 ROW RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 64 ROW RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 65 ROW RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 66 ROW RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 67 ROW RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 68 RADIOIMMUNOASSAY (RIA) KITS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Table 69 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Table 70 DIASORIN S.P.A: REVENUE MIX, 2010-2014 (USD MILLION)
Table 71 MERCK MILLIPORE CORPORATION: KEY FINANCIALS, 2010-2014 (USD MILLION)
Table 72 STRATEC BIOMEDICAL AG: REVENUE MIX, 2010-2014 (USD MILLION)
Table 73 DANAHER CORPORATIONS: KEY FINANCIALS, 2011-2014 (USD MILLION)
Table 74 PERKINELMER, INC.: KEY FINANCIALS, 2010-2014 (USD MILLION)
Table 75 TECAN TRADING AG: KEY FINANCIALS, 2010-2014 (USD MILLION)
Table 1 IMMUNOASSAY MARKET SIZE & RADIOIMMUNOASSAY MARKET SIZE, 2014 (USD MILLION)
Table 2 RADIOIMMUNOASSAY (RIA) MARKET: COMPARISON WITH IMMUNOASSAY MARKET (PARENT MARKET), 2013–2020 (USD MILLION)
Table 3 RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 4 RADIOIMMUNOASSAY (RIA) MARKET, BY END-USER, 2013-2020 (USD MILLION)
Table 5 RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 6 RADIOIMMUNOASSAY MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 7 RADIOIMMUNOASSAY (RIA) MARKET: DRIVERS AND INHIBITORS
Table 8 RADIOIMMUNOASSAY MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 9 RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 10 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 11 RADIOIMMUNOASSAY (RIA) MARKET, BY END-USERS, 2013–2020 (USD MILLION)
Table 12 RADIOIMMUNOASSAY (RIA) MARKET IN HOSPITALS, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 13 RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY AND CRO, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 14 RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 15 RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2013–2020 (USD MILLION)
Table 16 RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 17 RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 18 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 19 RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 20 RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 21 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 22 RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 23 RADIOIMMUNOASSAY (RIA) MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
Table 24 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 25 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 26 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 27 EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 28 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 29 GERMANY RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 30 GERMANY RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 31 FRANCE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 32 FRANCE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 33 U.K. RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 34 U.K. RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 35 ITALY RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 36 ITALY RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 37 SPAIN RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 38 SPAIN RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 39 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 40 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 41 NORTH AMERICA RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 42 NORTH AMERICA RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 43 NORTH-AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY END-USER, 2013-2020 (USD MILLION)
Table 44 U.S. RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 45 U.S. RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 46 CANADA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 47 CANADA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 48 MEXICO RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 49 MEXICO RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 50 ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 51 ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 52 ASIA RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 53 ASIA RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 54 ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 55 CHINA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 56 CHINA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 57 JAPAN RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 58 JAPAN RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 59 INDIA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 60 INDIA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 61 REPUBLIC OF KOREA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 62 REPUBLIC OF KOREA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 63 ROW RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
Table 64 ROW RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 65 ROW RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 66 ROW RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
Table 67 ROW RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2013-2020 (USD MILLION)
Table 68 RADIOIMMUNOASSAY (RIA) KITS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Table 69 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Table 70 DIASORIN S.P.A: REVENUE MIX, 2010-2014 (USD MILLION)
Table 71 MERCK MILLIPORE CORPORATION: KEY FINANCIALS, 2010-2014 (USD MILLION)
Table 72 STRATEC BIOMEDICAL AG: REVENUE MIX, 2010-2014 (USD MILLION)
Table 73 DANAHER CORPORATIONS: KEY FINANCIALS, 2011-2014 (USD MILLION)
Table 74 PERKINELMER, INC.: KEY FINANCIALS, 2010-2014 (USD MILLION)
Table 75 TECAN TRADING AG: KEY FINANCIALS, 2010-2014 (USD MILLION)
LIST OF FIGURES
Figure 1 RADIOIMMUNOASSAY (RIA) MARKET SEGMENTATION & COVERAGE
Figure 2 RADIOIMMUNOASSAY (RIA) MARKET: INTEGRATED ECOSYSTEM
Figure 3 TOP-DOWN APPROACH
Figure 4 MACRO INDICATOR-BASED APPROACH
Figure 5 RADIOIMMUNOASSAY (RIA) MARKET SNAPSHOT, 2014 (%)
Figure 6 RADIOIMMUNOASSAY (RIA) MARKET, COMPARISON WITH IMMUNOASSAY MARKET (PARENT MARKET), 2013-2020 (USD MILLION)
Figure 7 RADIOIMMUNOASSAY (RIA) TYPE MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
Figure 8 RADIOIMMUNOASSAY (RIA) END USER MARKET, BY GEOGRAPHY, 2014 (USD MILLION)
Figure 9 RADIOIMMUNOASSAY (RIA) APPLICATION MARKET, BY GEOGRAPHY, 2014 (USD MILLION)
Figure 10 RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
Figure 11 RADIOIMMUNOASSAY (RIA) MARKET, TYPE COMPARISON WITH PARENT MARKET, 2013-2020 (USD MILLION)
Figure 12 RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 13 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 14 RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2014 & 2020 (USD MILLION)
Figure 15 RADIOIMMUNOASSAY (RIA) HOSPITALS MARKET, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 16 RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY AND CRO, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 17 RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 18 RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 19 RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
Figure 20 RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 21 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 22 RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 23 RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 24 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 25 RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 26 EUROPE RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 27 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
Figure 28 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
Figure 29 EUROPE RADIOIMMUNOASSAY MARKET (RIA), BY END USER, 2014 & 2020 (USD MILLION)
Figure 30 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY COUNTRY, 2014 & 2020 (USD MILLION)
Figure 31 GERMANY RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 32 FRANCE RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 33 U.K. RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW, 2014 & 2020 (%)
Figure 34 ITALY RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 & 2020 (%)
Figure 35 SPAIN RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW 2014 & 2020 (%)
Figure 36 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 37 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
Figure 38 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
Figure 39 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2014 & 2020 (USD MILLION)
Figure 40 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY COUNTRY, 2014 & 2020, (USD MILLION)
Figure 41 U.S. RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW 2014 & 2020 (%)
Figure 42 CANADA RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 43 MEXICO RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 44 ASIA RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 45 ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
Figure 46 ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
Figure 47 ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2014 & 2020 (USD MILLION)
Figure 48 ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY COUNTRY, 2014 & 2020 (USD MILLION)
Figure 49 CHINA RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 50 JAPAN RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 &2020 (%)
Figure 51 INDIA RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 & 2020 (%)
Figure 52 REPUBLIC OF KOREA RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 & 2020 (%)
Figure 53 ROW RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 54 ROW RADIOIMMUNOASSAY (RIA) MARKET, BY COUNTRY, 2014 & 2020 (USD MILLION)
Figure 55 ROW RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
Figure 56 ROW RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
Figure 57 ROW RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2014 & 2020 (USD MILLION)
Figure 58 RADIOIMMUNOASSAY (RIA) KITS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Figure 59 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Figure 60 RADIOIMMUNOASSAY (RIA) MARKET: KEY PLAYERS OPERATING IN APPLICATION AREAS
Figure 61 RADIOIMMUNOASSAY (RIA) MARKET: COVERAGE OF KEY PLAYERS BY APPLICATION
Figure 62 DIASORIN S.P.A: REVENUE MIX 2014(%)
Figure 63 DIASORIN S.P.A: KEY FINANCIALS, 2010-2014 (USD MILLION)
Figure 64 MERCK MILLIPORE CORPORATION: KEY FINANCIALS, 2010-2014 (USD MILLION)
Figure 65 STRATEC BIOMEDICAL AG: KEY FINANCIALS, 2010-2014 (USD MILLION)
Figure 66 DANAHER CORPORATIONS: REVENUE MIX, 2014 (%)
Figure 67 PERKINELMER, INC.: REVENUE MIX, 2014 (%)
Figure 68 TECAN TRADING AG: REVENUE MIX, 2014 (%)
Figure 1 RADIOIMMUNOASSAY (RIA) MARKET SEGMENTATION & COVERAGE
Figure 2 RADIOIMMUNOASSAY (RIA) MARKET: INTEGRATED ECOSYSTEM
Figure 3 TOP-DOWN APPROACH
Figure 4 MACRO INDICATOR-BASED APPROACH
Figure 5 RADIOIMMUNOASSAY (RIA) MARKET SNAPSHOT, 2014 (%)
Figure 6 RADIOIMMUNOASSAY (RIA) MARKET, COMPARISON WITH IMMUNOASSAY MARKET (PARENT MARKET), 2013-2020 (USD MILLION)
Figure 7 RADIOIMMUNOASSAY (RIA) TYPE MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
Figure 8 RADIOIMMUNOASSAY (RIA) END USER MARKET, BY GEOGRAPHY, 2014 (USD MILLION)
Figure 9 RADIOIMMUNOASSAY (RIA) APPLICATION MARKET, BY GEOGRAPHY, 2014 (USD MILLION)
Figure 10 RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
Figure 11 RADIOIMMUNOASSAY (RIA) MARKET, TYPE COMPARISON WITH PARENT MARKET, 2013-2020 (USD MILLION)
Figure 12 RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 13 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 14 RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2014 & 2020 (USD MILLION)
Figure 15 RADIOIMMUNOASSAY (RIA) HOSPITALS MARKET, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 16 RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY AND CRO, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 17 RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 18 RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 19 RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
Figure 20 RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 21 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 22 RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 23 RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 24 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 25 RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2014 & 2020 (USD MILLION)
Figure 26 EUROPE RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 27 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
Figure 28 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
Figure 29 EUROPE RADIOIMMUNOASSAY MARKET (RIA), BY END USER, 2014 & 2020 (USD MILLION)
Figure 30 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY COUNTRY, 2014 & 2020 (USD MILLION)
Figure 31 GERMANY RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 32 FRANCE RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 33 U.K. RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW, 2014 & 2020 (%)
Figure 34 ITALY RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 & 2020 (%)
Figure 35 SPAIN RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW 2014 & 2020 (%)
Figure 36 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 37 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
Figure 38 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
Figure 39 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2014 & 2020 (USD MILLION)
Figure 40 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, BY COUNTRY, 2014 & 2020, (USD MILLION)
Figure 41 U.S. RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW 2014 & 2020 (%)
Figure 42 CANADA RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 43 MEXICO RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 44 ASIA RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 45 ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
Figure 46 ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
Figure 47 ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2014 & 2020 (USD MILLION)
Figure 48 ASIA RADIOIMMUNOASSAY (RIA) MARKET, BY COUNTRY, 2014 & 2020 (USD MILLION)
Figure 49 CHINA RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 50 JAPAN RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 &2020 (%)
Figure 51 INDIA RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 & 2020 (%)
Figure 52 REPUBLIC OF KOREA RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 & 2020 (%)
Figure 53 ROW RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%)
Figure 54 ROW RADIOIMMUNOASSAY (RIA) MARKET, BY COUNTRY, 2014 & 2020 (USD MILLION)
Figure 55 ROW RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2014 & 2020 (USD MILLION)
Figure 56 ROW RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
Figure 57 ROW RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2014 & 2020 (USD MILLION)
Figure 58 RADIOIMMUNOASSAY (RIA) KITS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Figure 59 RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
Figure 60 RADIOIMMUNOASSAY (RIA) MARKET: KEY PLAYERS OPERATING IN APPLICATION AREAS
Figure 61 RADIOIMMUNOASSAY (RIA) MARKET: COVERAGE OF KEY PLAYERS BY APPLICATION
Figure 62 DIASORIN S.P.A: REVENUE MIX 2014(%)
Figure 63 DIASORIN S.P.A: KEY FINANCIALS, 2010-2014 (USD MILLION)
Figure 64 MERCK MILLIPORE CORPORATION: KEY FINANCIALS, 2010-2014 (USD MILLION)
Figure 65 STRATEC BIOMEDICAL AG: KEY FINANCIALS, 2010-2014 (USD MILLION)
Figure 66 DANAHER CORPORATIONS: REVENUE MIX, 2014 (%)
Figure 67 PERKINELMER, INC.: REVENUE MIX, 2014 (%)
Figure 68 TECAN TRADING AG: REVENUE MIX, 2014 (%)
